Trial intelligence / Profile preview

Oral Probiotics for Anxiety and Depression in Adolescents After Surgery

NCT07640490Phase 1Completed

Sponsor
Henan Provincial People's Hospital
Start
Aug 2025
Primary completion
May 2026
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in anxiety disorder and major depressive disorder (MDD) (2 arms), sponsored by Henan Provincial People's Hospital. Primary endpoints: Anxiety scale scores at 2 months and Depression scale scores at 2 months. Started Aug 2025; status: completed.

02

Conditions

anxiety disordermajor depressive disorder (MDD)

Beyond the preview

Go deeper on NCT07640490.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07640490.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call